-
Daily variability of non-motor symptoms as a reflection of circadian dysregulation in Parkinson’s disease
-
Dancing larynx syndrome associated with trigeminal neuralgia secondary to multiple sclerosis
-
Data quality, acceptability and reliability of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS)
-
Day Hospitals Reinvented : the future of Parkinson’s care
-
Daytime Sleepiness Effects on Motor Symptoms in De Novo Parkinson’s Disease
-
Daytime sleepiness in Parkinson’s disease: an indicator of impaired activities of daily living
-
DBS for Parkinson-Dementia syndrome: Stimulation of both Globus Pallidus internus & the Nucleus Basalis of Meynert using the same electrode lead
-
DBS for PD in Albania
-
DBS in Parkinson’s disease: Experience from Egypt
-
DBS Programming In Tremor And Akinetic-Rigid Predominant Parkinson’s Disease
-
DCM extract of Scutellaria Pinnatifida modulate alpha-synuclein fibrillation and protects dopaminergic SH-SY5Y cells against rotenone
-
Deceleration capacity of heart rate: is cardiac vagal modulation impaired in idiopathic Parkinson’s disease?
-
Deciphering Corticobasal Syndrome: are clinical features and FDG-PET imaging capable of predicting amiloyd status?
-
Deciphering the role of posttranslational modifications on α-synuclein aggregation and toxicity
-
Decline in Neural Connectivity in Olfactory Spatial Attention: A Comparative Study in the Progression of Parkinson’s Disease
-
Decreased baroreflex sensitivity in Parkinson’s disease is associated with orthostatic hypotension
-
Decreased Cannabinoid Type 1 Receptor Density in Parkinson’s Disease: A [18F]FMPEP-d2 PET Study
-
Decreased serum alpha-synuclein in patients with Restless Legs Syndrome and association with SNCA-Rep1 polymorphism
-
Deep Brain Stimulation (DBS) clinical impedance measurements of the Medtronic Clinician 8840 versus the Samsung Galaxy Tab S2 tablet interface
-
Deep Brain Stimulation (DBS) in Pantothenate Kinase-Associated Neurodegeneration (PKAN): An Experience in a Thai Patient
-
Deep Brain Stimulation as a Rescue When Duodenal Levodopa Infusion Fails: Report of 2 Cases
-
Deep Brain Stimulation as second line advanced treatment for PD after LCIG
-
Deep Brain Stimulation for atypical tremors secondary to Neuroferritinopathy: Single center experience
-
Deep Brain Stimulation for Parkinson’s disease: the Paradox of More Technological Approaches
-
Deep brain stimulation in children: analysis of indication, outcome and complications
-
Deep Brain Stimulation in Early-Stage Parkinson’s Disease Provides Long-Term Rest Tremor Benefit Through Five Years
-
Deep Brain Stimulation in Parkinson’s Disease: Experience of the Neurology Department of Marrakesh
-
Deep brain stimulation in patients with chronic anti-coagulation treatment: a series of 35 patients
-
Deep brain stimulation of Caudal Zona incerta: Case series
-
Deep Brain Stimulation of Subthalamic Nucleus (DBS-STN) in Parkinson Disease (PD): Acute Clinical Effects in Hypothalamic control
-
Deep Brain Stimulation of the Subthalamic Nucleus and Globus Pallidus for apathy in PD patients
-
Deep Brain Stimulation of VIM Thalamic Nucleus for Tremor Control
-
Deep Brain Stimulation Wash-in/out Periods Quantified using a Palm-Worn Device to Monitor Rigidity
-
Deep brain stimulation-guided optogenetic rescue of parkinsonian symptoms
-
Deep mitochondrial sequencing in Parkinson’s disease reveals possible genetic modifiers of reduced penetrance in Parkin/PINK1 mutation carriers
-
Deep phenotyping adult onset isolated cervical dystonia; the importance of symptomatic anxiety and depression.
-
Defective human motion perception in cervical dystonia correlates with coexisting tremor
-
Defence Mechanism of Ego and Coping Strategy Style of the Patient with Parkinson’s Disease
-
Defining biomarkers to discriminate between organic and functional dystonia
-
Dementia with Lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile
-
Demographic Influences on Wearing Off Symptoms in Parkinson’s Disease
-
Dentate nucleus functional connectivity changes and their relationship with motor and non motor symptoms in patients with essential tremor
-
Dentatorubral-Pallidoluysian Atrophy outside of Asia: A case report of the first Austrian family harbouring this rare mutation
-
Depression and anxiety in cervical dystonia
-
Depression and cognitive impairment in isolated focal-onset dystonia: prevalence and risk factors in a group of Romanian patients
-
Depression as a risk factor for impulse compulsive disorders in Parkinson’s disease: a prospective survival study
-
Depression in Parkinson’s diseaese: Experience of the neurology department in Mohammed VI third level university hospital
-
Depression, Anxiety and Sleep Disturbances in Patients with Craniocervical Dystonias
-
Depressive Symptoms are Associated with Lower Locus Coeruleus Volumes in Parkinson’s disease
-
Describing Dystonia Phenomenology and Preliminary Treatment Response in Migraine Patients
-
Descriptive Presentation of MRI Findings in Multiple Sclerosis Patients with Tonic Spasm
-
Design and Baseline Characteristics of an Open-Label, Randomized, 26-Week Study Comparing Levodopa-Carbidopa Intestinal Gel to Optimized Medical Treatment on Non-Motor Symptoms in Patients with Advanced Parkinson’s Disease – INSIGHTS Study
-
Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation
-
Design, characterization and In vivo evaluation of intranasal delivery of levodopa loaded microspere for Parkinsonism
-
Detecting unsuspected mitochondrial disease: an algorithmic approach
-
Detection of genetic modifiers in PRKN
-
Detection of impaired finger dexterity by objective keyboard typing test in Parkinson’s Disease: A feasibility study
-
Determining Outcome of Deep Brain Stimulation Surgery in Parkinson’s Disease Patients
-
Developing an innovative telephone support line for people with Parkinson’s Disease
-
Development and Validation of the Parkinson’s Disease Medication Adherence Scale (PD- MAS)
-
Development of a patient-reported Botulinum Toxin Response Scale (BTRS) for neurological disorders: a feasibility study.
-
Development of a Predictive Model for Progressive Supranuclear Palsy Using Real World Data
-
Development of a questionnaire to assess sensory trick in patients with dystonia
-
Development of a web-based tool for systematic collection of phenotypes of hereditary movement disorders from medical literature
-
Development of an unsupervised analysis pipeline for human microelectrode recordings
-
Development Of Anti-Parkinsonism Poly Herbal Sustained Release Formulation Composed Of Potential Traditional Plant Extracts
-
Development of Mucoadhesive Sustained Release Floating Tablets of Silymarin using Natural Polymer for Improved Anti-Parkinson Efficacy
-
Diagnosing Dementia with Lewy Bodies – Characterizing the prevalence and underlying relationships between core and supportive clinical features
-
Diagnosis and management strategies used in series of Parkinson’s disease patients who experienced subthalamic nucleus deep brain stimulation induced mood elevation
-
Diagnosis and Treatment Experiences in a Real-World Sample of Tourette Syndrome and Tic Disorder Sufferers
-
Diagnostic accuracy of Progressive Supranuclear Palsy: Experience of a movement disorders center
-
Diagnostic journeys of people with Parkinson’s disease in Kenya, sub-Saharan Africa
-
Diagnostic potential of automated diffusion imaging for the differential diagnosis of multiple system atrophy and Parkinson’s disease
-
Dielectric Properties of a Blood Plasma Predict Motor Deficits in a 6-Hydroxydopamine-Induced Rat Model of Parkinson’s Disease
-
Dietary Vitamin E as a protective factor for Parkinson’s Disease: a clinical and experimental study
-
Difference in perception of the wearing-off between patients and physicians in Parkinson’s disease
-
Differences in botulinum toxin long-term treated and non-treated cervical dystonia patients in somatosensory task-related functional imaging response.
-
Differences in correlation with cardiac sympathetic denervation between depression and anhedonia in drug naïve Parkinson disease patients
-
Differences in resting state fMRI distinguish multiple system atrophy and Parkinson disease
-
Different clinical entities of Segawa syndrome within a family
-
Different patterns of brain activity during lower limb movements in Parkinson’s disease patients with and without freezing of gait
-
Different patterns of cortical and subcortical perfusion changes in essential tremor and tremor-dominant Parkinson’s disease using voxel-based analysis of 3D arterial spin-labeling imaging
-
Differential diagnosis of Parkinsonian Syndromes – combining clinical and imaging data in a machine-learning approach
-
Differential effects of stem cell therapy in adult and middle-aged Parkinsonian mice
-
Differential effects of stimulation amplitude and lead laterality of deep brain stimulation of the subthalamic nucleus on speech and Parkinsonian motor symptoms
-
Differential enhancement of ERK, PKA and Ca2+ signaling in direct and indirect striatal neurons of Parkinsonian mice
-
Differential Gait Progression in idiopathic Parkinson’s disease with and without freezing of gait
-
Differential Gene Expression in Parkinson Disease and Chronic Traumatic Encephalopathy
-
Differential Item Functioning in the Unified Dyskinesia Rating Scale (UDysRS) based on Duration of Parkinson’s Disease and Dyskinesia
-
Differential temporal processing across Lewy body disorders and relation to cognitive fluctuations
-
Differential Value of Brain Magnetic Resonance Imaging in MSA-C and SCAs
-
Differentiating the substantia nigra pars compacta and ventral tegmental area in early-stage Parkinson’s disease using quantitative susceptibility mapping
-
Differentiation of Progressive Supranuclear Paralysis from Multisystem Atrophy and Parkinson’s Disease by Cranial MRI
-
Digenic inheritance of WARS2 and CHRNA6 mutations in infantile parkinsonism
-
Digital biomarker sensor feature data reflect quality of life judgements (PDQ39) in recently diagnosed Parkinson’s disease patients
-
Digital monitoring of Huntington’s disease with smartphone and smartwatch wearable technology: The Digital-HD study
-
Diplopia and visual complaints in non-demented patients with Parkinson disease: a Japanese single center cross-sectional survey
-
Directional Deep Brain Stimulation Lead Implantation: A Single Center Experience
-
Directional deep brain stimulation: what’s for?
-
Directional lead local field potentials show distinct spatial resolution
-
Directional leads in deep brain stimulation – surgical handling and evolving therapy options
-
Directional stimulation for Dystonic tremor
-
Directional versus omnidirectional Deep Brain Stimulation for Parkinson’s disease: Results of a prospective, blinded, multi‑center, single-arm crossover study
-
Discriminative power of different olfactory domains in Parkinson’s disease
-
Disease-in-a-dish: drug discovery using patient-derived stem cells in Hereditary Spastic Paraplegia
-
Disrupted Functional Brain Connectome in Parkinson’s Disease Patients with Freezing of Gait
-
Disrupted salience network dynamics in Parkinson´s disease patients with impulse control disorders
-
Dissecting the genetic complexity of Parkinson’s disease: a Parkin-GBA study
-
Distinct neuronal correlates underpin impulsive action and impulsive choice in Tourette disorder
-
Distinct phenotypic expression in a large PKAN cohort in the Dominican Republic
-
Distributed Global Functional Connectivity Networks Predict Responsiveness to L-DOPA and Subthalamic Deep Brain Stimulation
-
Distribution Characteristics of Limbs Discomfort in Restless Legs Syndrome
-
DNAJC13 in Parkinson’s disease; characterization of the p.N855S knock-in mouse model
-
Do non-motor fluctuations temporarily match ON/OFF motor condition?
-
Does Anticholinergic Burden Affect the Outcomes in Patients Diagnosed with Parkinson’s Disease?
-
Does automated analysis of repeat DaTscan imaging aid diagnosis in suspected Lewy body disorders?
-
Does cognitive-motor training improve the balance in Parkinson’s disease? Randomized clinical trial
-
Does Deep Brain Stimulation in Parkinson’s Disease Change Disease Progression in the Long Run?
-
Does Gait in Real Life differ between People with Parkinson’s Disease and Healthy Controls?
-
Does information from the Personal KinetiGraph™ (PKG) influence neurologists´ treatment decisions?
-
Does lesion localisation predict tremor characteristics in patients with focal cerebellar lesion?
-
Does microelectrode recording increase haemorrhage? A comparative study in a large patient cohort over 20 years
-
Does Physical Activity impact Resting State Functional Connectivity in Parkinson Disease Patients?
-
Does REM Sleep Behavior Disorder Change in the Progression of Parkinson’s Disease?
-
Does socio-economic status have impact on quality of life in persons with Parkinson’s disease?
-
Does Team-based Outpatient Palliative Care Improve Patient or Care Partner-Centered Outcomes in Parkinson’s Disease and Related Disorders?
-
Does the magnitude of improvement of UPDRS III at the preoperative L-dopa test predict the degree of medication decrease one year after subthalamic nucleus Deep Brain Stimulation?
-
Does the truth lie within the gut? Investigating the gut microbiome in an Australian cohort of Parkinson’s disease patients
-
Does Transcranial Direct Current Simulation Improve Motor Functions in Patients with Parkinson’s disease?
-
Domain-specific impact of mood/anxiety disorders on quality of life in idiopathic dystonia
-
Dopamine agonist withdrawal syndrome in Sardinian patients affected by Parkinson’s disease
-
Dopamine dysregulation syndrome and levodopa-induced dyskinesias in patients with Parkinson’s disease on the background of deep stimulation of the subthalamic nucleus
-
Dopamine receptor variants alter outcomes with levodopa in early-stage Parkinson’s disease
-
Dopamine substitution increases connectivity between premotor and motor areas in Parkinson’s disease – a DCM-Study
-
Dopaminergic imaging in patients with basal ganglia calcification presenting with parkinsonism
-
Dopaminergic Neuroregeneration in the Diencephalon of 6-OHDA-Lesioned Adult Zebrafish-Based Parkinson’s Disease Model
-
Dorsolateral striatal neuronal activity in a rat model of Parkinson`s disease with levodopa-induced dyskinesias
-
Drooling in Parkinson’s Disease: A [123I]FP-CIT SPECT study
-
Drug Utilization in a Real World Cohort with Progressive Supranuclear Palsy
-
Drug-induced dystonia
-
Drug-induced Negative Myoclonus: A Case Report
-
Drug-Induced Parkinsonism May Persist Beyond Two Years After Discontinuation of Dopamine Transmission Blocking Agents
-
Dry eye in Parkinson’s disease: symptoms, consequences and treatment options
-
Dual-task in Parkinson’s disease: a gait analysis and functional MRI study
-
Duloxetine for pain in Parkinsons disease; A single center double blind randomised placebo controlled trial.
-
Duration of rimabotulinumtoxinB action in the treatment of adult sialorrhea
-
Dyadic analysis of the Parkinson’s disease impact on the patient-spouse couple
-
Dynamic causal modelling of cortical activity in task-specific dystonia
-
Dynamic functional connectivity signature of cognitive decline in Parkinson’s disease
-
Dynamics of Device-based Treatments for Parkinson´s Disease in Germany from 2010 – 2017
-
Dysautonomia as a predictor of cognitive outcome after deep brain stimulation in Parkinson’s disease
-
Dysbiosis of Gut Microbiota in a selected population of Italian Parkinson’s Disease patients
-
Dyskinesia Rates in Patients with Parkinson’s Disease on CVT-301 (levodopa inhalation powder)
-
Dysphagia in Adults with Niemann-Pick Disease Type C
-
Dysregulated long non-coding RNA in Parkinson’s disease contributes to the apoptosis of dopaminergic neuron
-
Dystonia as a main clinical feature of AAMR with a novel GMPPA mutation:A case report
-
Dystonic opisthotonus: A clinical clue to neurodegeneration with brain iron accumulation in young adults
-
Dystonic storm with a change of stimulation from constant voltage to constant current
-
Dystonic tics in patients with Gilles de la Tourette syndrome
-
Dystonic versus parkinsonian tremor
2019 International Congress
September 22-26, 2019. Nice, France.